Generic placeholder image



ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Research Article

Dual Modulators of Selected Plant Secondary Metabolites Targeting COVID-19 Main Protease and Interleukin-2: An In-Silico Approach based Novel Hypothesis

Author(s): Thangavelu Prabha, Vijay K. Kapoor, Palanisamy Selvamani, Subbiah Latha, Thangavel Sivakumar and Selvaraj Jubie*

Volume 2, Issue 2, 2021

Published on: 29 September, 2020

Page: [223 - 234] Pages: 12

DOI: 10.2174/2666796701999200929124556


Background: Owing to the recent scenario on this ongoing Coronavirus pandemic outbreak around the world, the present study has been undertaken.

Aim: In this study, we adopted two strategies, i.e., via computational method, a search for the novel plant secondary metabolites from the Indian Traditional Medicine to target and combat the enduring novel 2019 CoVs main protease that causes pneumonia, followed by the effect of these selected secondary metabolites on the host’s immune system for their immunomodulatory potential on Interleukin-2.

Methods: A detailed literature review has been done to identify the assorted plant secondary metabolites from the natural sources, which have been extensively used traditionally for their immunomodulatory potential. Next, the resulting compounds have processed for the molecular docking study to predict whether the compounds have the potency to fight against 2019- CoVs protein or it could have the tendency to battle the cytokines, which are responsible for the immune response of the host, thereby preventing the CoVs caused infection in humans. Furthermore, to explore molecular mechanics, the insilico docking study with COVID-19 Mpro and Interleukin-2 has been performed.

Results & Discussion: Among the six secondary metabolites selected, five compounds showed its possible promising potency with COVID-19 and IL-2 proteins, which are compared with the standard drug Remdesivir, one of the anti-viral drugs for treating and managing the present coronavirus condition and an IL-2 inhibitor, which is the native IL-2 ligand protein (i.e., from PDB Id- 1PW6) itself. Besides, based on the docking scores, the Curcumin (from Curcuma longa) showed the highest score towards these two targets taken for this study. The identified compounds have a promising binding affinity with the Mpro receptors, in the narrow range of binding energy for the protein PDB Id: 6LU7 and the score range between -10.9102 to -19.8790 kcal/mol: when compared to the standard -21.8600 kcal/mol. Whereas, the binding affinity with the Interleukin -2 receptor, for the protein PDB Id: 1PW6 the range between -11.3899 to -17.1366 kcal/mol: when compared to that of standard -16.9554 kcal/mol.

Conclusion: Our result findings demonstrate that the integrated Indian traditional herbal treatment might be hopefully used for the viral respiratory infection due to either it may have acted directly on the viral protein or through regulating the immune response, which could lead to the rapid drug discovery of the drug leads with clinical potency towards the novel infectious disease, where there is no drug or vaccines are available.

Keywords: CoVs-19, Wuhan coronavirus, molecular docking, immune response, mpro viral protein, Coronavirus disease (COVID-19).

Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33.
[] [PMID: 31978945]
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected pneumonia. N Engl J Med 2020; 382(13): 1199-207.
[] [PMID: 31995857]
Cheng SC, Chang YC, Chiang YLF, et al. First case of Coronavirus Disease 2019(COVID-19) pneumonia in Taiwan. J Formos Med Assoc 2020; 119: 747-51.
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.
[] [PMID: 32015508]
Masters PS, Perlman S. In: Knipe, DM, Howley, PM, Eds. Fields Virology. Philadelphia:Lippincott Williams Wilkins 2013.
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17(3): 181-92.
[] [PMID: 30531947]
Dhama K, Pawaiya R, Chakraborty S, Tiwari R, Saminathan M, Verma A. Coronavirus infection in equines: a review. Asian J Anim Vet Adv 2014; 9(3): 164-76.
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3)105924
[] [PMID: 32081636]
World Health Organization Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance Available from:] (Accessed March 19, 2020).
World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from: .
Government of India. Available from: .
Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017; 9(11): 1211.
[] [PMID: 29099763]
Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020; 18(2): 152-8.
[] [PMID: 32113846]
Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res 2004; 18(7): 592-4.
[] [PMID: 15305324]
World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems Geneva, Switzerland. Available from:.
Wenbo Y, Feng W, Hui W. Immunomodulation of artemisinin and its derivatives. Sci Bull (Beijing) 2016; 61(18): 1399-406.
Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators inspired by nature: a review on curcumin and echinacea. Molecules 2018; 23(11): 2778-94.
[] [PMID: 30373170]
Madhuri S, Pandey G, Verma KS. Antioxidant, immunomodulatory and anticancer activities of emblica officinalis: an overview. Inter Res J Pharma 2011; 2(8): 38-42.
Rana A, Arnab M, Sayantika M, Biswadev B. Immunomodulatory and anti-oxidant properties of methanolic extract of Adhatoda vasica leaf after particulate antigen stimulation in mice. J Pharma Res 2014; 8(10): 1520-37.
Haw-Wen C, Chin-Shiu H, Pei-Fen L, et al. Andrographis paniculata extract and andrographolide modulate the hepatic drug metabolism system and plasma tolbutamide concentrations in rats. Evid Based Complement Alternat Med 2013; 2013982689
Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immunopharmacol 2009; 9(3): 313-8.
[] [PMID: 19110075]
Zhou J, Lu GD, Ong CS, Ong CN, Shen HM. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation. Mol Cancer Ther 2008; 7(7): 2170-80.
[] [PMID: 18645026]
Yu BC, Chang CK, Su CF, Cheng JT. Mediation of beta-endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals. Naunyn Schmiedebergs Arch Pharmacol 2008; 377(4-6): 529-40.
[] [PMID: 18080810]
Woo AY, Waye MM, Tsui SK, Yeung ST, Cheng CH. Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury. J Pharmacol Exp Ther 2008; 325(1): 226-35.
[] [PMID: 18174384]
Sheeja K, Kuttan G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther 2007; 6(1): 66-73.
[] [PMID: 17351028]
Iruretagoyena MI, Tobar JA, González PA, et al. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther 2005; 312(1): 366-72.
[] [PMID: 15331658]
Iruretagoyena MI, Sepúlveda SE, Lezana JP, et al. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006; 318(1): 59-67.
[] [PMID: 16597709]
Wang W, Wang J, Dong SF, et al. Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol Sin 2010; 31(2): 191-201.
[] [PMID: 20139902]
Li T, Chen H, Wei N, et al. Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity. Int Immunopharmacol 2012; 12(1): 144-50.
[] [PMID: 22122827]
Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017; 174(11): 1325-48.
[] [PMID: 27638428]
Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili SA, Johnston TP, Abdollahi E, Sahebkar A. Curcumin: a natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev 2018; 17(2): 125-35.
[] [PMID: 29180127]
Asolkar LV, Kakkar KK, Chakra OJ. Second supplement to glossary of Indian medicinal plants with active principles publication and information directorate New Delhi: Publications & Information Directorate (CSIR) 1992.
Dhuley JN. Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation-induced coughing in animals. J Ethnopharmacol 1999; 67(3): 361-5.
[] [PMID: 10617073]
Grange JM, Snell NJ. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J Ethnopharmacol 1996; 50(1): 49-53.
[] [PMID: 8778507]
Kumar SKP, Bhowmik D, Tiwari CP, Kharel R. Indian traditional herbs Adhatoda vasica and its medicinal application. J Chem Pharm Res 2010; 2: 240-5.
Sheikh R, Naresh KS, Rukmankesh M, et al. Anti-asthmatic activity of azepino [2, 1-b] quinazolones, synthetic analogues of vasicine, an alkaloid from Adhatoda vasica. Med Chem Res 2014; 23: 4269-79.
Gupta OP, Sharma ML, Ghatak BJR, Atal CK. Pharmacological investigations of vasicine and vasicinone--the alkaloids of Adhatoda vasica. Indian J Med Res 1977; 66(4): 680-91.
[PMID: 608735]
Ajith Y, Dimri U, Dixit SK, et al. Immunomodulatory basis of antioxidant therapy and its future prospects: an appraisal. Inflammopharmacol 2017; 25: 487-8.
Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J 2002; 21(13): 3213-24.
[] [PMID: 12093723]
Yang H, Yang M, Ding Y, et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA 2003; 100(23): 13190-5.
[] [PMID: 14585926]
Waters RS, Perry JSA, Han S, Bielekova B, Gedeon T. The effects of interleukin-2 on immune response regulation. Math Med Biol 2018; 35(1): 79-119.
[] [PMID: 28339682]
National Cancer Institute NCI Dictionary of Cancer TermsAvailable from:
Daily S. ScienceDeadly immune ‘storm’ caused by emergent flu infectionsAvailable from:
Chemical Computing Group. Molecular Operating Environment (MOE). Available from:.
Pillaiyar T, Manickam M, Namasivayam V, Hayashi Y, Jung SH. An overview of severe acute respiratory syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J Med Chem 2016; 59(14): 6595-628.
[] [PMID: 26878082]
Arenas-Ramirez N, Woytschak J, Boyman O. Interleukin-2: biology, design and application. Trends Immunol 2015; 36(12): 763-77.
[] [PMID: 26572555]
Smith AJP, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20(1): 43-59.
[] [PMID: 19038572]
Cava C, Bertoli G, Castiglioni I. In silico discovery of candidate drugs against Covid-19. Viruses 2020; 12(4): 404.
[] [PMID: 32268515]
Pedersen M, Andersen R, Nørgaard P, et al. Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease. Cancer Immunol Immunother 2014; 63(12): 1341-6.
[] [PMID: 25227926]
Jin Z, Du X, Xu Y, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv 2020; 2020: 1.
Thanos CD, Randal M, Wells JA. Potent small-molecule binding to a dynamic hot spot on IL-2. J Am Chem Soc 2003; 125(50): 15280-1.
[] [PMID: 14664558]
Chaolin H, Yeming W, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395: 497-506.
Mesaik MA, Jabeen A, Halim SA, et al. In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa. Chem Biol Drug Des 2012; 79(3): 290-9.
[] [PMID: 22181857]
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[] [PMID: 32015507]
Khodadadi S. Role of herbal medicine in boosting immune system. Immunopathol Persa 2015; 1(1)e01
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14(8): 523-34.
[] [PMID: 27344959]
Eakachai P, Chutitorn K, Tanapat P. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 2020; 38: 1-9.
Sobia AH. Zaheer-ul-Haq, Sauleha K. A comparative docking analysis for the virtual screening of interleukin-2 inhibitors. Int J Biol Biotechnol 2018; 15(1): 29-38.

© 2022 Bentham Science Publishers | Privacy Policy